WEST PHARMA DRN financial statements, including revenue, expenses, profit, and loss

The total revenue of W2ST34 for the last quarter is 3.44 B BRL, and it's 5.11% lower compared to the previous quarter. The net income of Q1 24 is 570.91 M BRL.